Tracy Doyle, CEO of Phoenix Group, describes how the speakers bureau is evolving in a digital economy, including opportunities related to advancing content using virtual reality and augmented reality, and the potential for using OTT and artificial intelligence to drive peer-to-peer engagement. This video is presented by Phoenix Group and produced by the MM&M Content Lab.
AI, wearables, and VR still reign supreme in the healthcare realm, and other things you missed
Caregivers and patients predict how the use of AI will affect them.
AI's marketing problem: Inflated claims, outsized expectations may actually be slowing AI's move into clinical practiceMarch 21, 2018
The potential is real, but companies and technology gurus often speak of machine learning as a catch-all solution. The hype may be slowing AI's incremental growth in healthcare, experts say.
Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled
Publicis Groupe has announced it has selected Microsoft has the technology partner to deliver its artificial intelligence platform Marcel.
As researchers and analysts, we interact with a wide array of market research pros in the health and wellness space.
Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations
Next year will be the start of the shift from marketing algorithms to AI, predicts Kantar Millward Brown.
Innovation-minded executives share their thoughts and predictions for the year ahead.
AI complements what we in pharma have always done best — respond to medical needs quickly and find solutions.
Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.
If there is one thing to take away from the opening day at the Cannes Lions International Festival of Creativity, it is this. Find the talks that inspire you, and then find the places with AC.
Google invests in European biotechs; hospitals that restrict sales-rep visits more likely to prescribe cheaper generics; AI could help doctors with new research
One executive referred to AI as a "black box" and as the "Tower of Babel."
Gilead receives approval to market Harvoni, Sovaldi to adolescents; OncoMed ends mid-stage trials for pancreatic cancer drug; researchers use facial recognition software to diagnose
SXSW's health track finally got a seat at the big-kids table.
Gilead exec blames PBMs for high drug prices; Google uses AI to detect signs of breast cancer; Sanofi and Regeneron drug effective in treating eczema
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
The internet strongly agrees there's an artificial intelligence revolution going on, and it's come to pharma marketing.